Pharmaceutical

Torrent Pharmaceuticals is set to acquire JB Chemicals in a landmark deal worth Rs. 19,500 crore, marking one of the largest acquisitions in India’s pharmaceutical industry. This strategic move not only strengthens Torrent’s position in the domestic branded generics market but also enhances its global footprint, particularly in regulated markets. The acquisition brings together two complementary portfolios, promising strong synergies across therapeutic areas and geographies.

Shares of Sigachi Industries Ltd suffered a sharp decline exceeding 11% after a catastrophic explosion at its pharmaceutical manufacturing plant in Telangana resulted in the deaths of at least 12 individuals and injured 34 others. The incident, which occurred in the company’s reactor unit within the Pashamylaram industrial estate, is believed to have been caused by a chemical reaction that triggered a fire. This tragedy not only raises serious safety concerns but also significantly impacted investor confidence, as reflected in the steep stock price fall on both the BSE and NSE.